If you need more lookups,
subscriptions start at $34 USD/month.
Amit Hasija Location
Tarrytown, NY, US
Amit Hasija Work
Chief Financial Officer and Executive Vice President of Corporate Development @ (September 2019 - Present)
Strategic Advisor @ (February 2019 - March 2020)
Chief Financial Officer and Chief Business Officer @ (May 2017 - January 2019)
Vice President U.S. Head of Integrated Care @ (January 2016 - January 2017)
Vice President Business Development @ (October 2012 - January 2016)
Director - Healthcare Investment Banking @ (September 2010 - October 2012)
Vice President - Investment Banking Healthcare Group @ (April 2004 - August 2010)
Associate @ (August 2002 - April 2004)
Planning Analyst @ (January 1995 - January 2000)
Amit Hasija Education
NYU Stern School of Business
MBA (Finance)
2000-2002
Drexel University
BS (Chemical Engineering)
1990-1995
Amit Hasija Skills
Investment Banking
Valuation
Financial Modeling
Corporate Finance
Due Diligence
Equities
Private Equity
Capital Markets
Hedge Funds
Fixed Income
Biotechnology Industry
Pharmaceutical Industry
Healthcare Information Technology (HIT)
Business Development
Cross-functional Team Leadership
Emerging Markets
Business Strategy
Strategic Planning
Venture Capital
Corporate Development
Strategy
Management
Healthcare Information Technology Hit
Risk Management
Cross Functional Team Leadership
Healthcare Information Technology
Amit Hasija Summary
Amit Hasija, based in Tarrytown, NY, US, is currently a Chief Financial Officer and Executive Vice President of Corporate Development at Milestone Pharmaceuticals, Inc.. Amit Hasija brings experience from previous roles at Araim Pharmaceuticals, Inc., Fulcrum Therapeutics and Sanofi. Amit Hasija holds a 2000 - 2002 MBA in Finance @ NYU Stern School of Business. With a robust skill set that includes Investment Banking, Valuation, Financial Modeling, Corporate Finance, Due Diligence and more. Amit Hasija has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Amit Hasija?
Find contact details for 700 million professionals.